Ilan Oren - 31 Oct 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren
Issuer symbol
ROIV
Transactions as of
31 Oct 2022
Net transactions value
$0
Form type
4
Filing time
02 Nov 2022, 17:58:29 UTC
Previous filing
19 Sep 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +2,796 +5.1% $0.000000 58,161 31 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.